Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20180384 levofloxacin metronidazole prodrug vs comparator in pelvic anaerobic infection
CTR20180384Phase 2Completed
- Sponsor
- Nanjing Hailing Pharmaceutical
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levofloxacin + metronidazole phosphate in Pelviabdominal infection, endometritis, Salpingitis, adnexitis, Tubo-ovarian abscess (TOA), sponsored by Nanjing Hailing Pharmaceutical. Started Dec 2018; status: completed.
02
Drugs
levofloxacin + metronidazole phosphate
03
Conditions
Pelviabdominal infectionendometritisSalpingitisadnexitisTubo-ovarian abscess (TOA)
Beyond the preview
Go deeper on CTR20180384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180384.